Business & Purchasing Guides

The GLP-1 market is entering a new era. In early Semaglutide vs. Tirzepatide 2025, Zepbound® Tirzenize tirzepatide officially surpassed Wegovy® Semanize semaglutide in U.S. sales, signaling a dramatic shift in clinical and financial landscapes. For weight-loss clinics, medical spas, and metabolic centers, the question isn’t just which drug works better—it’s which one delivers stronger profit…

The math has changed semaglutide for obesity treatment in 2025. With semaglutide prices skyrocketing and insurers tightening coverage, patients now face a complex financial maze. Here’s what you need to know to navigate the new reality. 2025 Cost Reality Check Brand-Name Pricing (Before Insurance) Drug Monthly Cost Dose Wegovy® $1,350-$1,600 2.4mg pen Ozempic® $950-$1,200 1mg…